Drawing for POOLBEG PHARMA

USPTO serial 79404743

POOLBEG PHARMA

Reviewed by CopyMark Law Group

Reg. 7862619Status 700Registered
Filing date
Status date
Registration date
Jul 15, 2025
Examiner
FARRAG, SHERIF G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with POOLBEG PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Usha Menon

Usha Menon D'Ambrosio & Menon, PLLC3 Sugar Creek Center Blvd.Suite 100Sugar Land, TX 77478

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, namely, psychotropics, antihelmintics, lipid lowering agents, and pharmaceuticals for the treatment of skin disorders, dermatological conditions, respiratory diseases and asthma, cancer, baldness, heart disease, cardiovascular disorders, allergies, muscle injuries and disorders, erectile dysfunction, viral diseases, hormonal disorders, infectious diseases, bone diseases, stretch marks, eyes diseases and eye conditions, gastro-intestinal diseases, psychiatric diseases and disorders, immune system related diseases and disorders, insomnia, neuropathic pain, sinus congestion, blood disorders, pain, inflammation, obesity and cognitive disorders, ocular diseases or disorders, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; vaccines, reagents for medical use; medical and veterinary preparations for the diagnosis and treatment of infectious diseases; sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; medical and surgical plasters, materials for dressings being gauze for medical and surgical dressings and wadding for medical and surgical dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicidesACTIVE—
035Advertising services for pharmaceuticals, reagents for medical use, medical drugs and vaccines; advertising services relating to pharmaceuticals; business management in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business advisory services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business administration in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial consultancy in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial intermediation services, namely business intermediary services relating to the matching of buyers and sellers of medical products in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; negotiating and concluding commercial transactions for others in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; providing business assistance in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccine product commercialization; commercial lobbying services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial information in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial management assistance in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; preparation of commercial business reports in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; collection of commercial information being market research information relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; provision of information concerning commercial sales relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; compilation of business statistics and commercial information relating to the field of pharmaceuticals, medical drugs and vaccines; business management consultancy and advisory services relating to the field of pharmaceuticals, medical drugs and vaccines; computerised business management for others relating to the field of pharmaceuticals, medical drugs and vaccines; provision of commercial information from online databases relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business management of reimbursement programmes for others relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business administration of medication reimbursement programs and services; provision of an online marketplace for buyers and sellers of pharmaceuticals, reagents for medical use, medical drugs and vaccines; sales promotion for others of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business opportunity promotion in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; promotion services, namely, advertising services for the promotion of goods and services of others; promotional and advertising services; promoting the sale of goods and services of others through promotional events in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; database management relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials; database marketing, advertising, and promotion relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials, for others; compiling of information into computer databases relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials; compilation of information into computer databases relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials; retail and online retail store services or wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and online retail store services or wholesale store services relating to medical instruments and devices, pharmaceuticals, reagents for medical use, drugs and vaccinesACTIVE—
042Scientific and technological services being the scientific research relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical clinical trials, and design relating thereto; industrial research services in the field of pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical clinical trials and industrial analysis thereof; design and development of computer hardware and software; software as a service (SAAS) services featuring software for use in the communication and dissemination of medical and pharmaceutical information and for providing clinical trial information and results; providing online, non-downloadable software for the communication and dissemination of medical and pharmaceutical information and for providing clinical trial information and results; hosting online web facilities for others for conducting interactive discussions; hosting of digital content online being the electronic storage of electronic data; online data storage being cloud storage services for electronic data; platform as a service (PAAS) featuring computer software platforms for use in the communication and dissemination of medical and pharmaceutical information and for providing clinical trial information and results; hosting software platforms for collaboration on medical and pharmaceutical products on the Internet for others; hosting of communication platforms being software for others on the internet; hosting of e-commerce platforms being software for others on the Internet; scientific research services and the preparation of technical reports relating to pharmaceuticals, reagents for medical use, drugs and vaccines thereto; technical research relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; providing scientific information in the field of medical disorders and their treatment; database design and development; design and development of pharmaceutical, medical drug, vaccine and medical trial databases; maintaining online databases for scientific research purposes of pharmaceuticals, medical drugs, vaccines and medical trials for others; medical and pharmacological research services; medical research relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; scientific research for medical purposes; provision of information and data relating to medical and veterinary research and development; research and development in the field of biotechnology; biotechnology testing being scientific research in the field of biotechnology; testing of pharmaceuticals for quality control purposes for others; technical testing services relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines being quality control services for others; testing, authentication and evaluation being quality control of pharmaceuticals, reagents for medical use, medical drugs and vaccines; scientific and technological consultancy relating to biotechnology; electronic storage of medical records; medical research laboratory services; design and development of medical technology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the nature of conducting clinical trials for others; research and development of vaccines and medicines; drug discovery services; pharmaceutical drug development services; pharmaceutical research services; pharmaceutical product evaluation; pharmaceutical research and development servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 26, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 11, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 11, 2026FIMPFINAL DISPOSITION PROCESSED—
Oct 29, 2025LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 15, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 15, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 15, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 27, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 21, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 13, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 13, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2024LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Nov 9, 2024RFNTREFUSAL PROCESSED BY IB—
Oct 24, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 24, 2024RFRRREFUSAL PROCESSED BY MPU—
Oct 19, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 18, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2024DOCKASSIGNED TO EXAMINER—
Sep 24, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 24, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance